Overcoming the limitations of current meta-analysis of randomised controlled trials
暂无分享,去创建一个
[1] S. Yusuf,et al. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. , 1997, Controlled clinical trials.
[2] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[3] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[4] J. Grotta,et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery , 1997, Neurology.
[5] M. Valsecchi,et al. A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] J. Darbyshire,et al. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals , 1996, The Lancet.
[7] S. Connolly,et al. Dual-chamber versus ventricular pacing. Critical appraisal of current data. , 1996, Circulation.
[8] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[9] N. Maine,et al. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi , 1996, The Lancet.
[10] I Olkin,et al. Meta-analysis of randomized controlled trials. A concern for standards;. , 1995 .
[11] C. Redmond,et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.
[12] S. Pocock,et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.
[13] C. Furberg,et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. , 1995, Circulation.
[14] J. P. Pignon,et al. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.
[15] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[16] I Olkin,et al. Statistical and theoretical considerations in meta-analysis. , 1995, Journal of clinical epidemiology.
[17] N Victor,et al. "The challenge of meta-analysis": discussion. Indications and contra-indications for meta-analysis. , 1995, Journal of clinical epidemiology.
[18] R. Slavin. Best evidence synthesis: an intelligent alternative to meta-analysis. , 1995, Journal of clinical epidemiology.
[19] C Anello,et al. Exploratory or analytic meta-analysis: should we distinguish between them? , 1995, Journal of clinical epidemiology.
[20] D. Cook,et al. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. , 1995, Journal of clinical epidemiology.
[21] K. Dickersin,et al. Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .
[22] L. Stewart,et al. Systematic Reviews: Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? , 1994, BMJ.
[23] J L Pater. Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) perspective. , 1994, Statistics in medicine.
[24] Jeffrey R. Wilson,et al. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.
[25] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[26] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[27] I. Chalmers. The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care , 1993, Annals of the New York Academy of Sciences.
[28] S. Yusuf,et al. Intravenous Magnesium in Acute Myocardial Infarction An Effective, Safe, Simple, and Inexpensive Intervention , 1993, Circulation.
[29] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[30] T C Chalmers,et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.
[31] S. Fletcher,et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) , 1992, The Lancet.
[32] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[33] C. Begg,et al. Publication bias : a problem in interpreting medical data , 1988 .
[34] R Peto,et al. Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.
[35] C. Furberg,et al. Lessons from overviews of cardiovascular trials. , 1987, Statistics in medicine.
[36] T C Chalmers,et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.
[37] S. Yusuf. Obtaining medically meaningful answers from an overview of randomized clinical trials. , 1987, Statistics in medicine.
[38] A. Sommer,et al. IMPACT OF VITAMIN A SUPPLEMENTATION ON CHILDHOOD MORTALITY A Randomised Controlled Community Trial , 1986, The Lancet.
[39] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[40] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[41] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[42] R Peto,et al. Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.
[43] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[44] D L DeMets,et al. An aid to data monitoring in long-term clinical trials. , 1982, Controlled clinical trials.
[45] R. Rosenthal. The file drawer problem and tolerance for null results , 1979 .